skip to main content

New Medicine Service asthma — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

EasyPatient Counselling and Pharmaceutical CareNew Medicine Service asthmaGPhC CRA

A patient starting a preventer inhaler is eligible for a structured follow-up service. They have previously stopped medicines when symptoms improved. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: E — Offer support focused on adherence, technique and concerns

The New Medicine Service supports adherence and early problem-solving for selected long-term medicines. Inhaler technique and beliefs about preventers are important in asthma. In this scenario, the correct option is offer support focused on adherence, technique and concerns. The other options are plausible but do not address the key clinical, legal or safety issue as directly. This aligns with UK pharmacy practice guidance cited in the reference field.

Reference: NHS NMS guidance; GPhC Standards